Assignee
SMARTCELLS INC
US·8 granted patents·3 pending applications·35 citations·filing 2006–2017
Top patents by PatentIndex Score
11 records- 0191US7687608B2Methods for reducing the mitogenicity of lectin compositionsSMARTCELLS INC·Filed 2006·Granted Mar 30, 2010·21 cites·11 claims
- 0287US9114176B2Exogenously triggered controlled release materials and uses thereofSMARTCELLS INC·Filed 2014·Granted Aug 25, 2015·4 cites·13 claims
- 0384US9463249B2Crystalline insulin-conjugatesSMARTCELLS INC·Filed 2014·Granted Oct 11, 2016·5 cites·13 claims
- 0481US9579391B2Conjugate based systems for controlled drug deliverySMARTCELLS INC·Filed 2015·Granted Feb 28, 2017·2 cites·22 claims
- 0579US9265838B2Conjugate based systems for controlled drug deliverySMARTCELLS INC·Filed 2014·Granted Feb 23, 2016·2 cites·20 claims
- 0678US10398781B2Conjugate based systems for controlled drug deliverySMARTCELLS INC·Filed 2017·Granted Sep 3, 2019·1 cites·20 claims
- 0766US9745355B2Binding-site modified lectins and uses thereofSMARTCELLS INC·Filed 2014·Granted Aug 29, 2017·0 cites·4 claims
- 0856US2016193351A1Conjugate based systems for controlled drug deliverySMARTCELLS INC·Filed 2016·Application pending·0 cites
- 0955US2014037699A1Soluble non-depot insulin conjugates and uses thereofSMARTCELLS INC·Filed 2013·Application pending·0 cites
- 1052US9095623B2Terminally-functionalized conjugates and uses thereofSMARTCELLS INC·Filed 2013·Granted Aug 4, 2015·0 cites·13 claims
- 1152US2017022262A1Crystalline insulin-conjugatesSMARTCELLS INC·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →